miR-21 is documented to be overexpressed in ER-positive BC lines and promote tamoxifen and fulvestrant resistance by targeting phosphatase and tensin homolog (PTEN) of the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signaling pathway in BC [82]. This evidence concerns the gene ESR1 and breast cancer.